Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Short term Debt (2016 - 2023)

Aethlon Medical filings provide 13 years of Short term Debt readings, the most recent being $214221.0 for Q1 2023.

  • On a quarterly basis, Short term Debt rose 37.55% to $214221.0 in Q1 2023 year-over-year; TTM through Mar 2023 was $214221.0, a 37.55% increase, with the full-year FY2023 number at $214221.0, up 37.55% from a year prior.
  • Short term Debt hit $214221.0 in Q1 2023 for Aethlon Medical, up from $190397.0 in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $214221.0 in Q1 2023 to a low of $83654.0 in Q1 2019.
  • Median Short term Debt over the past 5 years was $131844.0 (2020), compared with a mean of $138988.8.
  • Biggest five-year swings in Short term Debt: surged 59.44% in 2019 and later decreased 14.47% in 2021.
  • Aethlon Medical's Short term Debt stood at $111212.0 in 2019, then grew by 18.46% to $131746.0 in 2020, then dropped by 1.04% to $130375.0 in 2021, then soared by 46.04% to $190397.0 in 2022, then increased by 12.51% to $214221.0 in 2023.
  • The last three reported values for Short term Debt were $214221.0 (Q1 2023), $190397.0 (Q4 2022), and $177527.0 (Q3 2022) per Business Quant data.